Under pressure: Ano1 mediates pressure sensing in the lymphatic system.
Under pressure: Ano1 mediates pressure sensing in the lymphatic system.
复制标题
在压力下:Ano1 介导淋巴系统中的压力感应。
DOI:
10.1085/jgp.201912320
复制
发表时间:
2019
期刊:
影响因子:
--
通讯作者:
Carlson,AnneE
中科院分区:
文献类型:
--
作者:
Tembo,Maiwase;Carlson,AnneE
Although identified only 11 years ago, the Ca2+-activated Cl− channel (CaCC), Ano1, is firmly established as an essential physiological protein. This channel is known by many names—TMEM16a, DOG1, ORAOV2, TAOS2—and mediates many more physiological processes. Several of these Ano1-regulated processes are seemingly disparate, ranging from mucosal secretion (Huang et al., 2012) to fertilization (Wozniak et al., 2018). However, the precise role of the channel is not necessarily as varied. Indeed, a recurring role for Ano1 in signaling the contraction of various types of smooth muscle is emerging. For example, Ano1 mediates parasympatheticinduced bronchi contraction in airway smooth muscle (Huang et al., 2012). In uterine smooth muscle, Ano1 promotes spontaneous and oxytocin-induced contractions (Bernstein et al., 2014). In some vascular smooth muscle, such as that surrounding the cerebral artery, Ano1 mediates stretch-activated constriction (Bulley et al., 2012). In this issue of the Journal of General Physiology, Zawieja et al. describe a new role for Ano1 as a mediator of pressure-sensitive contraction in lymphatic collecting vessels.In the lymphatic system, contraction of the smooth muscle surrounding lymphatic vessels enables the return of fluid and macromolecules from the interstitial space to the blood (Jones and Min, 2011). These lymphatic vessels exhibit spontaneous contractions with a pressure-dependent frequency such that fluid build-up results in vessel contractions in healthy tissues. Dysfunction of these vessels causes lymphedemas, defined as the abnormal buildup of fluid in extremities (Jones and Min, 2011). Because there are no existing cures for lymphedemas, afflicted patients have to bear with this disorder for the rest of their lives. A better understanding of the molecular and ionic mechanisms underlying contraction of these lymphatic collecting vessels may pave the way for the development of pharmaceutical therapies to treat and reverse lymphatic disorders. To explore whether Ano1 contributes to the regulation of lymphatic vessel contraction, Zawieja et al.(2019) first confirmed